RNS Number : 3628F
Braveheart Investment Group plc
04 March 2024
 

4 March 2024

 

Braveheart Investment Group Plc

("Braveheart", the "Company" or the "Group")

 

Completion of sale of Phasefocus

 

Braveheart Investment Group (AIM: BRH), is pleased to announce that, further to the announcement on 22 December 2023 regarding the sale of Phasefocus Holdings Limited ("Phasefocus") to Bruker UK Limited, all outstanding conditions to the sale have now been satisfied and the sale has therefore completed.  The total proceeds receivable by the Company for the Sale was approximately £2.1 million (after expenses).  

 

Trevor Brown, CEO of Braveheart, commented: "The sale of our holding in Phasefocus represents a gain of £1.31m over cost, which is a highly satisfactory CAGR of 48.29% for Braveheart shareholders."

 

For further information:

 

Braveheart Investment Group plc

Tel: 01738 587555

Trevor Brown, Chief Executive Officer

Viv Hallam, Executive Director


Allenby Capital Limited (Nominated Adviser and Joint Broker)

Tel: 020 3328 5656

James Reeve / George Payne




Peterhouse Capital Limited (Joint Broker)

Tel: 020 7469 0936

Duncan Vasey / Lucy Williams

 


 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISQKNBPBBKDBNK